Potti, A., Moazzam, N., Ramar, K., Hanekom, D.S., Kargas, S. and Koch, M. (2003) CD117 (c-KIT) Overexpression in Patients with Extensive-Stage Small-Cell Lung Carcinoma. Annals of Oncology, 14, 894-897. http://dx.doi.org/10.1093/annonc/mdg253

has been cited by the following article:

• TITLE: Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

  AUTHORS: Karin R. Purshouse

  KEYWORDS: Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development

  JOURNAL NAME: Advances in Lung Cancer, Vol.3 No.3, August 22, 2014

  ABSTRACT: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.